Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver ...

On Saturday, the U.S. Food and Drug Administration (FDA) approved an additional indication for Novo Nordisk A/S’ (NYSE:NVO) ...

U.S. shoppers looking for fake Christmas trees and holiday decor this year will have fewer choices and face higher prices as ...

World shares were mixed ahead of U.S. President Donald Trump’s meeting later Monday with Ukrainian President Volodymyr ...

HSBC Chief Multi-Asset Strategist Max Kettner says high-frequency data coming out of the US points to a better earnings ...

The upcoming meeting between Ukraine's President Volodymyr Zelenskiy and US President Donald Trump together with European ...

Anna Edwards, Guy Johnson, Kriti Gupta and Mark Cudmore break down today's key themes for analysts and investors on ...

The FTSE 100 and European markets were mixed in early trade on Monday as Ukrainian president Volodymyr Zelensky and a handful ...

Hundreds of thousands of Israelis took to the streets on Sunday to protest Prime Minister Benjamin Netanyahu's plan to expand ...

If there is one thing that is clear three months out from the Autumn Budget, it is that Chancellor Rachel Reeves will hike ...

Tesla's reduced production of its Cybertruck is having a ripple effect on owners, some of whom say insurance companies are ...

"It was extremely difficult," IgniteTech CEO Eric Vaughan tells Fortune. "But changing minds was harder than adding skills." ...